drugset / Trial / NCT07568470
Can the Phoenix Sign be Elicited With D5W
NaSequentialOpen-labelDiagnostic
Summary
To determine if the Phoenix sign can be reliably elicited with non-guided subcutaneous infiltration of D5W (5% Dextrose in Water) in patients with subclinical weakness of the extensor hallucis longus (EHL) muscle.
Timeline
- Start
- 2026-04-10
- Primary completion
- 2026-09-01
- Completion
- 2027-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | D5W | Unknown | 3 ml | Subcutaneous |
Indications
No indication recorded.